ArticleMolecular diagnosis & therapy2010
Cost-effectiveness analysis of KRAS testing and cetuximab as last-line therapy for colorectal cancer.
Takeru Shiroiwa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled itcites it